Skip to Content

Farmacias Benavides SAB de CV Class A BEVIDESA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BEVIDESA is trading at a 18% premium.
Price
MXN 14.99
Fair Value
MXN 45.81
Uncertainty
Very High
1-Star Price
MXN 25.36
5-Star Price
MXN 3.23
Economic Moat
Rqjnxk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BEVIDESA is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
MXN 0.05 / MXN 13.35
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
16.70
Price/Sales
0.51
Dividend Yield (Trailing)
2.14%
Dividend Yield (Forward)
Total Yield
2.14%

Company Profile

Farmacias Benavides SAB de CV is a drug store chain in Mexico. The company offers prescription and over-the-counter medications.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
7,619

Comparables

Valuation

Metric
BEVIDESA
GPROFUT
ASURB
Price/Earnings (Normalized)
16.7011.0016.89
Price/Book Value
4.143.86
Price/Sales
0.511.316.72
Price/Cash Flow
8.3713.91
Price/Earnings
BEVIDESA
GPROFUT
ASURB

Financial Strength

Metric
BEVIDESA
GPROFUT
ASURB
Quick Ratio
0.2412.853.47
Current Ratio
0.8412.853.88
Interest Coverage
1.9010.3412.79
Quick Ratio
BEVIDESA
GPROFUT
ASURB

Profitability

Metric
BEVIDESA
GPROFUT
ASURB
Return on Assets (Normalized)
1.89%2.22%15.96%
Return on Equity (Normalized)
137.96%23.25%26.49%
Return on Invested Capital (Normalized)
11.46%19.08%17.64%
Return on Assets
BEVIDESA
GPROFUT
ASURB
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncBgxjhgkMvs$15.4 Bil
RADLY
Raia Drogasil SA ADRDcbhpb$8.3 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRTmxjpzx$5.6 Bil
ALBHF
Alibaba Health Information Technology LtdQstpb$5.5 Bil
CLCGY
Clicks Group Ltd ADRVcsvss$3.6 Bil
TSUSF
Tsuruha Holdings IncPrnqz$3.1 Bil
SGIPF
Sugi Holdings Co LtdBlhr$2.8 Bil
SHPPF
Redcare Pharmacy NVNsxj$2.7 Bil
SAEYY
Redcare Pharmacy NV ADRGtt$2.6 Bil
ZRSEF
DocMorris AGYdrtk$1.1 Bil

Sponsor Center